Paid Clinical Trials Augusta

Discover 232 paid clinical trials in Augusta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 232

Androgen DeficiencyImproving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Recruiting

PHASE2

Sponsor:

Seattle Institute for Biomedical and Clinical Research

Location:

Augusta GA, Boston MA, Seattle WA

Code:

NCT04301765

Conditions

Hypogonadism, Male

Cancer

Fatigue

Eligibility Criteria

Sex: Male

Age: 55+

Healthy Volunteers: Not accepted

Interventions

testosterone 1.62% gel

placebo gel

Enhanced RecoveryCompliance With Enhanced Recovery After Surgery Protocol (ERAS) in Surgical Patients

Recruiting

Sponsor:

Augusta University

Location:

Augusta GA

Code:

NCT03968666

Conditions

Surgery

Anesthesia

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Solyx vs. RetropubicSingle-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy

Recruiting

Sponsor:

Wake Forest University Health Sciences

Location:

Augusta GA, Winston-Salem NC, Coconut Creek FL, Chicago ILshow 1 more

Code:

NCT04586166

Conditions

Stress Urinary Incontinence

Pelvic Floor Disorders

Eligibility Criteria

Sex: Female

Age: 21+

Healthy Volunteers: Not accepted

Interventions

RP Sling

SIS

EtavopivatA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Recruiting

PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Augusta GA, Greenville SC, Charleston SC, Atlanta GAshow 28 more

Code:

NCT06609226

Conditions

Sickle Cell Disease, Thalassemia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Etavopivat A

Etavopivat B

CrizanlizumabA Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Augusta GA, Riverdale GA, Jacksonville FL, Greenville NCshow 1 more

Code:

NCT06439082

Conditions

Sickle Cell Disease

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Crizanlizumab

Placebo

Radiation Therapy with AtezolizumabStudy of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Augusta GA, Newnan GA, Birmingham AL, Lexington KYshow 101 more

Code:

NCT04310020

Conditions

Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage III Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Magnetic Resonance Imaging

TX000045A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)

Recruiting

PHASE2

Sponsor:

Tectonic Therapeutic

Location:

Augusta GA, Rock Hill SC, McDonough GA, Jacksonville FLshow 21 more

Code:

NCT06616974

Conditions

Pulmonary Hypertension

Heart Failure With Preserved Ejection Fraction

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TX000045- Dose A

TX000045- Dose B

Placebo

DonanemabA Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Augusta GA, Columbia SC, Anderson SC, Union SCshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

Steroids & TKIsTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Augusta GA, Greenville SC, Easley SC, Seneca SCshow 142 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine

BI 771716A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Augusta GA, Charleston SC, Lynchburg VA, Nashville TNshow 42 more

Code:

NCT06722157

Conditions

Macular Degeneration, Age-related

Geographic Atrophy

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

BI 771716

Pegcetacoplan

Sham comparator to BI 771716